DOCSLIB.ORG

Malaysian Journal of Pharmacy (Vol 2 Issue 2)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Malaysian Journal of Pharmacy (Vol 2 Issue 2) PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society PP12684/8/2008 Vol. 2 Issue 2. August 2016 MALAYSIAN JOURNAL of PHARMACY In this issue: Supplement • Proceedings of the 9th National Pharmacy R&D Conference 2016 A Publication of the Malaysian Pharmaceutical Society EDITORIAL BOARD Malaysian Journal of Pharmacy Vol. 2 Issue 2. August 2016 The Official Journal of the Malaysian Pharmaceutical Society Editor-in-Chief: Assoc Prof Dr Asrul Akmal Shafie Managing Editor: Mr Ho Rhu Yann International Advisory Board: Assoc Prof Dr Chua Siew Siang Prof Dr Mohd Baidi Bahari Associate Editors: Mr Lam Kai Kun Prof Dr Mohamed Azmi Ahmad Hassali Assoc Prof Dr Mohamad Haniki Nik Mohamed Ms Syireen Alwi Prof P T Thomas Dr Wong Tin Wui Assoc Prof Dr Vikneswaran a/l Murugaiyah Prof Dr Yuen Kah Hay Publisher: Malaysian Pharmaceutical Society Malaysian Journal of Pharmacy 16-2 Jalan OP 1/5, 1-Puchong Business Park (the official journal of the Malaysian Off Jalan Puchong Pharmaceutical Society) 47160 Puchong c/o School of Pharmaceutical Sciences Malaysia Universiti Sains Malaysia Tel: 6-03-80791861 11800 Penang Fax: 6-03-80700388 MALAYSIA Homepage: www.mps.org.my Email: [email protected] Email: [email protected] The Malaysian Journal of Pharmacy is a publication of the Malaysian Pharmaceutical Society. Enquiries are to be directed to the publisher at the above address. The Publisher reserves copy- right and renewal on all published materials, and such material may not be reproduced in any form without the written permission of the Publisher. Table of Contents Editorial • Cross-disciplinary Research Fostering Holistic Healthcare 1 List of oral presentations 3 Abstracts of oral presentations 8 List of poster presentations 50 Abstracts of poster presentations 52 MALAYSIAN JOURNAL OF PHARMACY Vol. 2. Issue 2. August 2016 Editorial Cross-disciplinary Research Fostering Holistic Healthcare Dr. Lawrence Anchah Sarawak Heart Centre, Kota Samarahan, Sarawak, Malaysia Pharmacists play an important role in the multidisciplinary healthcare team who focus on pharmaceutical care issues. This is more apparent in hospitals and clinics, not forgetting those in community services. As our profession is increasingly focusing on holistic healthcare, good communication skill is crucial to provide guidance, counselling, education and know-how to meet the patient needs. Hence, future pharmacists are expected to undertake social pharmacy progressively in their practices to fulfill both pharmaceutical and social needs. In our current practices, medication non-adherence and pharmacy practice pattern are two common areas of discussion in our quest for providing better pharmaceutical care. Although patients’ adherence to their medications is close to 100% during admission (which is a Morisky Score of 8/8 or similar scale), there is a group of patients who are not adhere to their medication regime soon after discharge due to many reasons. It is challenging to resolve these issues during hospitalisation as patients are unable to assimilate the information provided during adherence counselling or during bedside dispensing activities. Hence, activities such as home medication review enable pharmacists to deliver better pharmaceutical care by working together with the patients and their caregivers. Pharmacists should take one step forward to break the over-the- counter barrier and serve the community by working together with other healthcare professionals from different specialties. This cross-disciplinary approach is able to reduce the risks of treatment failure as well as drug wastages. As we move towards providing better pharmacy services, the next challenging arena in clinical pharmacy nowadays is to provide personalized treatment. One of the examples is pharmacogenetics. The benefits of pharmacogenetics in individualised patient care are undisputed. However arguments still exist if one should opt for conventional empiric dosing strategy each time we encounter ‘tailored-to-patients’ needs. In the past, individualised pharmacogenetic-guided dosing is beyond our reach. This new approach of pharmacogenetics can bring a major impact in dose prediction particularly in warfarin and Noval Oral Anticoagulants (NOACs) therapies and thus possibly improve safety and cost effectiveness of the therapies. The cost and benefit of routine genotyping may take several more years for Malaysian practitioners to achieve a consensus. Until then, empiric-based dosing strategy is here to stay in our current clinical practice. Clearly a cross- disciplinary research is needed to work towards this direction. As the healthcare continues to evolve, healthcare professionals should not be restricted by their own disciplines and should move beyond their fields and explore new collaborative models with other healthcare professionals. The primary focus of such cross-disciplinary initiatives should be creating a network to support relatively clear-cut research goals in addressing the complex healthcare issues. By developing the cross-disciplinary teams, this may help support translational research and, by extension, the evidence for practices in fostering holistic healthcare. 1 MALAYSIAN JOURNAL OF PHARMACY Vol. 2. Issue 2. August 2016 ABSTRACT OF THE 9TH NATIONAL PHARMACY RESEARCH & DEVELOPMENT CONFERENCE 2016 Acknowledgements The editorial board would like to thank the Director General of Health, Malaysia for permission to publish the abstracts in this journal. Cross-Disciplinary Research: Fostering Holistic Healthcare Date: 8-10th August 2016 Reviewers of Abstracts Dr Lawrence Ak Anchah Dr Hasenah Ali Mr Leong Weng Choy Dr Liau Siow Yen Mr Hj Ridhwan Abdullah Dr Norkasihan Ibrahim Mdm Norazila Abd. Ghani Mdm Noorazlinda Yaacob Prof Yeoh Peng Nam Assoc Prof Dr Asrul Akmal Shafie Assoc Prof Dr Nahlah Elkudssiah Ismail Dr Azuana Ramli Dr Zaitulhusna Md Safee Dr Syamhanin Adnan Mdm Manjulaa Devi Subramanian Mdm Ching Shan Lii Mdm Farizan Abdul Ghaffar Mdm Sarah Diyana Mohd Shafie 2 MALAYSIAN JOURNAL OF PHARMACY Vol. 2. Issue 2. August 2016 LIST OF ORAL PRESENTATIONS No Presenting authors Title OP1-1 Liau Siow Yen Cytochrome P-450 Polymorphisms and its Relationship to Clopidogrel Response OP1-2 Fann Zi Yinn Benzodiazepine Utilization among Patients with Depressi3on in Teluk Intan Hospital OP1-3 Lee Sung Nying SL GTN: Assessment of Cardiac Patients’ Knowledge and Use at Balik Pulau Hospital OP1-4 Benjamin Loh Chuan Ching Impact of Value Added Services (VAS) on Patient Waiting Time at Ambulatory Pharmacy Queen Elizabeth Hospital OP1-5 Raja Mohd Khairul Anuar bin Study of Knowledge Identification and Safe-Handling Raja Ismail Practices of Cytotoxic Drug among Nurses in Raja Perempuan Zainab II Hospital (HRPZ II) OP1-6 King Teck Long High Prevalence of Aspirin Resistance in High Risk Coronary Artery Disease Patients and its Risk Factors OP1-7 Chan Huan Keat Pictogram-Based Labeling for Pediatric Liquid Medications: Impact on Caregivers’ Dosing Accuracy, Understanding and Preferences in the Sultanah Bahiyah Hospital, Alor Setar OP1-8 Norhayati Mustapha The Impact of Integrated Educational Programme on Knowledge, Attitude and Practices among HIV-Patient Caregivers OP1-9 Voon Ooi Tche Improvement of Asthma Clinical Outcomes in Pharmacist- Led Respiratory Medication Adherence Clinic (RMTAC) OP1-10 Goh See Yik The Capability of the Generic Pharmaceutical Industry in Malaysia: A Nationwide Study OP1-11 Chua Yi Wen Prevalence of Prescribing Error at Outpatient Clinic and Physician Clinic in Teluk Intan Hospital OP1-12 Siti Qurasyiah binti Abd A Comparison Study on the Prescribing Error in Discharge Hamid Prescription from Medical Ward in a Regional Referral Hospital OP1-13 Hamiza Binti Aziz Medication Adherence among Patients Receiving Subsidized Medication: Does the Rate Differ to Self- Paying Patients? OP1-14 Wong Wei Wei Safety-Related Knowledge, Attitude and Practices of Nurses Handling Cytotoxic Anticancer Drugs in Duchess of Kent Hospital OP1-15 Sze Wei Thing Impact of Pharmacist Initiated Antimicrobial Stewardship Strategies on Early Intravenous to Oral Antibiotics Switch Practice in District Hospitals OP1-16 Nadia Abdul Shukur Quality of Life and HAART Adherence among People Living with HIV (PLHIV) OP1-17 Lukman Nul Hakim bin Md Risk Factors and Clinical Outcomes of Patients with Khairi Multidrug Resistant Acinetobacter Baumannii Infection in Intensive Care Unit of HSNZ, Kuala Terengganu OP1-18 Arifah Nadiah binti Ahmad A Cross Sectional Survey on Self Medication Practice and Awareness among Public Attending Pasir Mas Kelantan, Hospital 3 MALAYSIAN JOURNAL OF PHARMACY Vol. 2. Issue 2. August 2016 No Presenting authors Title OP1-19 Loh Khai Lean Patients’ Belief, Knowledge and Adherence to Rheumatoid Arthritis Medication Pre and Post Pharmacist Counselling: A Pilot Study OP1-20 Melissa Lim Siaw Han CYP4F2 Gene Polymorphism and Warfarin Maintenance Dose in a Multiethnic Borneo Population on Long Term Warfarin Therapy OP1-21 Chow Li Wei Doctors’s Perceptions and Expectations of the Role of Clinical Pharmacists in a Regional Referral Hospital OP1-22 Chong Pei Feng The Prevalence of Polypharmacy in Elderly in the Medical Ward of a Malaysian
Load more

Recommended publications
  • Malaysia Terrorism Risk Review
    MALAYSIA TERRORISM RISK REVIEW SEPTEMBER, 2017 Intelligent Security Solutions Holding Limited Room 501, 5/f, Chung Ying Building 20 Connaught Road West Sheung Wan, Hong Kong Hong Kong Phone: +852 5619 7008 Thailand Phone: +66 97 120 6738 www.issrisk.com About Intelligent Security Solutions (ISS Risk) ISS Risk is a bespoke independent frontier, emerging, and selected developing markets political risk research, due diligence, and business solutions consulting company. ISS Risk has formed a highly qualified and experienced team with an extensive network of organic connections committed to providing clients with comprehensive, high-end quality information, intelligence, and security services. We specialise in the North East Asia region (China, Mongolia, DPRK, and South Korea); South Asia region (Myanmar, India, Pakistan, and Bangladesh); Central Asia (Kazakhstan, Kyrgyzstan, and Uzbekistan) and South East Asia region (Indonesia, Thailand and the Philippines). We have our headquarters based in Hong Kong with representation in DPRK, Mongolia, Myanmar, Philippines, Thailand, Shanghai, Beijing and India. Copyright Intelligent Security Solutions Limited. All rights reserved. Neither this publication nor any part of it may be reproduced, photocopied, stored in a retrieval system, or transmitted without the express prior consent of Intelligent Security Solutions Limited. Intelligent Security Solutions Limited Frontier & Emerging Markets Analysis Contents Introduction.............................................................................................................................................
    [Show full text]
  • (COVID-19) SITUATION in MALAYSIA 6 October 2020
    PRESS STATEMENT MINISTRY OF HEALTH MALAYSIA UPDATES ON THE CORONAVIRUS DISEASE 2019 (COVID-19) SITUATION IN MALAYSIA 6 October 2020 Current Status of Confirmed COVID-19 Cases Who Have Recovered The Ministry of Health (MOH) would like to inform that 87 cases have fully recovered and discharged today. Cumulatively, 10,427 confirmed COVID-19 cases have been discharged (77.2% of total cumulative cases). Current Situation of COVID-19 in Malaysia 6 October 2020, 12 pm, MOH would like to inform that 394 cases were detected in the Tembok Cluster, a prison in Kedah (i.e. 57.0% of the total cases reported today), 294 cases from other localities and three (3) imported cases. In total, 691 additional confirmed COVID-19 cases were reported to the National Crisis Preparedness and Response Centre (CPRC) MOH today. Cumulatively there are now 13,504 confirmed COVID-19 cases in Malaysia. Therefore, there are currently 2,936 active and infective COVID-19 cases. They have all been isolated and given treatment. Of the 691 cases reported today, three (3) are imported cases who were infected overseas, involving one (1) Malaysian and two (2) non- Malaysian who were travellers from: • India – 1 case reported in Kuala Lumpur, a Malaysian. • Egypt – 1 case reported in Sarawak, a non-Malaysian. • Philippines – 1 case reported in Selangor, a non-Malaysian. Of the 688 local transmission cases, 661 cases are Malaysians and 27 cases non-Malaysians. Of the 688 cases, 394 cases are those detected in the Tembok Cluster, a prison in Kedah (57.0% of total cases reported today).
    [Show full text]
  • Buku Panduan Jabatan Patologi 2018 HRPZ II
    HOSPITAL RAJA PEREMPUAN ZAINAB II KOTA BHARU KELANTAN Buku Panduan Jabatan Patologi HRPZ II 2018 KATA ALUAN PENGARAH JABATAN KESIHATAN NEGERI KELANTAN Assalamualaikum wbt. dan Salam Sejahtera. Terlebih dahulu, saya ingin merakamkan ucapan terima kasih kepada Jabatan Patologi, Hospital Raja Perempuan Zainab II kerana memberi kesempatan kepada saya untuk memuatkan kata-kata aluan di dalam Buku Panduan Jabatan. Bersyukur ke Hadrat Allah s.w.t. kerana dengan izin dan limpah kurniaNya, Buku Panduan Jabatan Patologi Edisi 2018 dapat diterbitkan dengan jayanya. Syabas dan tahniah kepada semua anggota Jabatan Patologi Hospital Raja Perempuan Zainab II yang telah menggembleng tenaga, pendapat dan pandangan untuk merealisasikan buku panduan ini. Adalah diharapkan agar kesemua hospital, klinik dan klinik kesihatan di Negeri Kelantan akan merujuk ujian- ujian tertentu yang mana tidak dilakukan di fasiliti mereka. Justeru, penerbitan buku panduan yang dilengkapkan dengan maklumat dan pengetahuan ini diharap dapat memberi manfaat kepada semua pelanggan dan anggota hospital. Usaha ini merupakan satu inisiatif dan tindakan proaktif Jabatan Patologi dan rangkaiannya untuk memberi panduan tentang Perkhidmatan Patologi di Hospital Raja Perempuan Zainab II Akhir kata, saya berharap penerbitan buku panduan ini dapat dijadikan sumber rujukan agar usaha- usaha penambahbaikan yang berterusan dapat dilakukan oleh Jabatan Patologi Hospital Raja Perempuan Zainab II. Dalam usaha untuk memantap dan memajukan sistem Perkhidmatan Patologi, Jabatan Kesihatan Negeri Kelantan sentiasa memberi penekanan yang sewajarnya dalam pelaksanaan pelbagai program yang berkaitan dengan Perkhidmatan Patologi. “ Jabatan Patologi Hospital Raja Perempuan Zainab II Sedia Membantu “ DATO’ DR. AHMAD RAZIN BIN DATO’ HAJI AHMAD MAHIR Pengarah Jabatan Kesihatan Negeri Kelantan i Buku Panduan Jabatan Patologi HRPZ II 2018 KATA ALUAN PENGARAH HRPZ II Assalamualaikum wbt.
    [Show full text]
  • 1. MOA AAA 2016 Abstract
    Abstract Combined Meeting of the th Malaysian Orthopaedic 46Association Annual General Meeting / Annual Scientific Meeting th ASEAN Arthroplasty 10 Association Meeting 2016 Fundamentals In Orthopaedics – Back To Basics Pre-Conference Day Conference Days 25th May 2016 26th to 28th May 2016 Persada Johor International Convention Centre, Johor Bahru, Malaysia. www.moa-home.com Abstract CD (Please click on the links below to view the respective categories of abstracts.) Oral Presentations Abstracts Poster Presentations Abstracts (Click Here...) Combined Meeting of the 46th Malaysian Orthopaedic Association Annual General Meeting / Annual Scientific Meeting & 10th ASEAN Arthroplasty Association Meeting 2016 26th May 2016 (Thursday) - Lecture Hall MOA 1, Level 3 TIME TOPIC SPEAKER 0700 -1730 REGISTRATION COUNTER OPENS SUBIR SENGUPTA MEMORIAL LECTURE Chairperson Prof Dr Saw Aik 0830 - 0900 Prevention And Early Detection Of DDH - The Japanese SM 01 Prof Dr Makoto Kamegaya Experience OPENING CEREMONY 0900 - 1030 Orthopaedics At The Frontlines In A Changing Globalised World. SK 01 Roles And Responsibilities. Dato' Dr Ahmad Faizal Mohd Perdaus A View From A Humanitarian And Colleauge. 1030 - 1100 TEA BREAK & EXHIBIT VISIT SPORTS Dr Shamsul Iskandar Hussein Chairperson Dr Raymond Yeak Dieu Kiat Revision Anterior Cruciate Ligament Reconstruction: Analysis 1100 - 1112 SX 01 Of Causes Of Failures, Preoperative Clinical Evaluation And Dr Deepak V. Patel Planning, Surgical Technique, And Clinical Outcomes SLAP (Superior Labrum Anterior Posterior)
    [Show full text]
  • Nursing Division Ministry of Health Malaysia
    NURSING DIVISION MINISTRY OF HEALTH MALAYSIA First Edition Mei 2017 SAFE OPERATING PROSEDURE FOR ADMINISTRATION OF INTRAVENOUS ( BOLUS ) EDICATION SAFE OPERATING PROSEDURE FOR ADMINISTRATION OF INTRAVENOUS ( BOLUS ) EDICATION ACKNOWLEDGEMENT Nursing Division Ministry of Health Malaysia gratefully acknowledges the expert contributions made by the following members, without whom the development of this consensus document would not be possible. ADVISOR Puan Hajah Rosena binti Abdul Ghani Director of Nursing Division, MOH EDITIORS Dr. Nor’Aishah Binti Abu Bakar Head of Patient Safety Unit Senior Public Health Physician & Senior Principle Assistant Director Medical Care Quality Section Medical Development Division, Ministry of Health Malaysia Puan Monica Chee Soon Nyuk Senior Assistant Director of Nursing, Nursing Division, MOH Puan Ng Siew Luan Nursing Matron, Nursing Division, MOH TECHNICAL WORKING GROUP Puan Darmawan binti Ramli Nursing Tutor, Unit Curriculum, Nursing Division, MOH Puan Suzana binti Jaafar Assistant Director, Nursing Division. MOH Puan Norlaila binti Mohd Husin Assistant Director, Nursing Division. MOH Puan Zanita binti Ahmad Clinical Nursing Matron, Family Health Development Division, MOH Puan Razmiyah binti Awang Nursing Matron, Nursing Division, MOH Puan See Booi Cheng Nursing Matron, Family Health Development Division, MOH Puan Noor Wati binti Esa Nursing Matron, Kuala Lumpur General Hospital Puan Mariati binti Alias Nursing Matron, Putrajaya Hospital Puan Noorsiah binti Harun Nursing Matron, Kajang Hospital Puan Zalimah
    [Show full text]
  • Direktori Pegawai Farmasi Pusat Rtg Methadone
    DIREKTORI PUSAT RTG METHADONE BAHAGIAN PERKHIDMATAN FARMASI KEMENTERIAN KESIHATAN MALAYSIA Edisi September 2010 KANDUNGAN PUSAT RAWATAN NEGERI PERLIS ............................................................................................................ 4 1. HOSPITAL ......................................................................................................................................... 4 2. KLINIK KESIHATAN ........................................................................................................................... 4 PUSAT RAWATAN NEGERI KEDAH ............................................................................................................ 5 1. HOSPITAL ......................................................................................................................................... 5 2. KLINIK KESIHATAN .......................................................................................................................... 6 3. PENJARA .......................................................................................................................................... 9 4. AGENSI ANTI DADAH KEBANGSAAN ............................................................................................. 10 PUSAT RAWATAN NEGERI PULAU PINANG ............................................................................................ 11 1. HOSPITAL ....................................................................................................................................... 11 2. KLINIK
    [Show full text]
  • Changing of the Guard
    MONASH PHARMACY AND PHARMACEUTICAL SCIENCES Changing of the Guard Meet our new Dean Going Global: The faculty’s ISSUE 34 • SUMMERISSUE 34 2019/20 increasingly international face John and Nariel Ware endow new scholarship Alumni news Fast Facts 2017 CLARIVATE ANALYTICS HIGHLY CITED RESEARCHERS (2004–2014) No.1 worldwide in Pharmacology and Toxicology QS WORLD UNIVERSITY RANKINGS BY SUBJECT, PHARMACY AND PHARMACOLOGY No.1 in Australia and Asia-Pacific 2018 No.1 worldwide for academic reputation 2018 No.2 worldwide 2018 Top 10 worldwide (average 2011–2018) Excellence in Research for Australia 2015 Top rating of 5 in all sectors (well above world standard) PharmAlliance with University of North Carolina at Chapel Hill, US and University College London, UK National Alliance for Pharmacy Education with University of Queensland, University of Sydney University of South Australia MONASH PHARMACY AND PHARMACEUTICAL SCIENCES Fast Facts Contents 02 News in brief Alchemy is produced 2017 CLARIVATE ANALYTICS by the Development Office, HIGHLY CITED RESEARCHERS (2004–2014) 04 Dean Charman steps down Faculty of Pharmacy and Pharmaceutical Sciences, No.1 worldwide in Pharmacology and Toxicology 06 Research with impact Monash University. Managing Editor: John Palmer 10 Special feature: Going global Writers: Rahul Ratwatte, Cyndi Ferguson, QS WORLD UNIVERSITY RANKINGS BY SUBJECT, Divya Krishnan 11 Monash University Malaysia’s School of Pharmacy Design: BPO Intelligence PHARMACY AND PHARMACOLOGY celebrates 10 years Photography: Paul Philipson and Greg Ford
    [Show full text]
  • Supplemental Data
    Appendix: Omega 3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group The FAVOURED Study Collaborative Group comprises the Trial Steering Committee (Chen Au Peh [CNARTS, Royal Adelaide Hospital, Adelaide, Australia], Elaine Beller [Faculty of Health Services and Medicine, Bond University, Gold Coast, Australia], Alan Cass [School Menzies School of Health Research, Darwin, Australia], Sharan Dogra [Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia], David Gracey [Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia], Elvie Haluszkiewicz [Department of Vascular Surgery, Royal Perth Hospital, Perth, Australia], Carmel Hawley [Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia], Lai-Seong Hooi [Hemodialysis Unit, Hospital Sultanah Aminah, Johor Bahru, Malaysia], Colin Hutchison [Renal Services, Hawkes Bay Hospital, Hawke’s Bay, New Zealand], Ashley Irish [Department of Nephrology Fiona Stanley Hospital, Perth, Western Australia, Australia], Peter Kerr [Department of Nephrology, Monash Medical Centre, Melbourne, Australia], Amanda Mather [Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia], Stephen McDonald [CNARTS, Royal Adelaide Hospital, Adelaide, Australia], Chris McIntyre [London Health Sciences Centre, Ontario, Canada], Trevor Mori [Medical School, RPH Unit, The University of Western Australia, Perth, Australia], Elaine Pascoe [Australasian Kidney Trials Network,
    [Show full text]
  • 534.1.Full.Pdf
    534 Thursday, 14 June 2018 Scientific Abstracts Ann Rheum Dis: first published as 10.1136/annrheumdis-2018-eular.6917 on 12 June 2018. Downloaded from 1.65; 95% CI 1.29–2.09); this was not observed in HFpEF (RR 0.80; 95% CI 63 (19.4%) had RA, 58 (17.8%) had pSS, 47 (14.5%) had SLE. Overall, 98 0.63–1.01). Following HF diagnosis, RA patients were more likely to be hospital- (30.2%) patients died. The survival rate of pSS-ILD(85.1%) and SLE-ILD(79.3%) ised for non-cardiovascular causes (RR 1.26; 95% CI 1.14–1.39), but not for HF were significantly higher than other CTD-ILDs [SSc-ILD(68.5%), RA-ILD(66.7%), (RR 0.96; 95% CI 0.76–1.21) or other cardiovascular causes (RR 0.99; 95% CI PM/DM-ILD(58.6%), p=0.009]. However, after categorised into three different ILD 0.81–1.20) compared to the non-RA patients. Readmission rates within 30 days imaging subtypes, it showed no statistical differences in survival rates (64.5%, of prior discharge were similar in RA and non-RA (p=0.14). Smoking (current or 73.6%, 69.5% of the UIP group, NSIP group, indeterminate group, respectively, former), prior myocardial infarction (MI) and higher score on Charlson comorbidity p=0.558). Multivariable analysis revealed that compared with DM/PM-ILD, the index were associated with increased risk for hospitalisation: hazard ratio (HR) mortality rate was significantly lower in pSS-ILD(RR=0.321, p=0.001), RA-ILD 1.33, 95% CI 1.06–1.68; HR 1.37, 95% CI 1.03–1.82; and HR 1.10, 95% CI 1.06– (RR=0.466, p=0.016), SSc-ILD(RR=0.566, p=0.045), and SLE-ILD patients 1.14, respectively.
    [Show full text]
  • Crc Sabah Newsletter
    Issue 3 : September– December 2013 CRC SABAH NEWSLETTER Inside This Issue WELCOME TO ISSUE 3 OF CRC NEWSLETTER Welcome to Issue 3 of CRC Sabah Newletter Warmest Greeting from CRC Sabah! Welcome 2014, and Happy Investigator Initiated Research (IIR) New Year! As we begin this New Year, we hope that 2014 will and industry Sponsored Research bring bigger and better things for the Clinical Research Centre (ISR) updates (CRC). Activities and Photo Gallery In This issue, we want to announce the upcoming workshop organized by CRC Sabah for the year 2014. Contact Us 1. Good Clinical Practice (GCP) Workshop collaboration Upcoming Events with Clinical Research Malaysia (CRM) 19th – 21st Feb 2014, Sabah Women and Children Hospital. 2. Sabah Good Clinical Practice (GCP) Workshop 26th – 28th Mar 2014, Hospital Queen Elizabeth II. CRC’s OBJECTIVE 3. Basic to Intermediate Medical Biostatistics Using SPSS Workshop 2014 1. To promote a culture of 14 – 17 April 2014, School Of Medical, University Malaysia research among healthcare Sabah (UMS). workers in Sabah. 4. Advanced Medical Biostatistics Using SPSS Workshop 2014 2 – 6 Jun 2014, School Of Medical, University Malaysia Sabah (UMS). 2. To disseminate skills in Grab this opportunity and never stop Learning! See you there! Methodology, Statistical tools, and techniques in designing and conducting clinical trials. CRC’s Vision 3. To provide healthcare workers the principle of methodology and To be a leading clinical research institution in Asia biostatistics in clinical research CRC’s Mission To improve patients health outcomes through ethical and quality clinical research. ISSUE 3: September – December 2013 CRC Sabah Newsletter MESSAGE AND RESOLUTION CRC SABAH HEAD 2014 First and foremost, I would like to congratulate the editorial team for their success in publishing the third edition of CRC Sabah Newsletter.
    [Show full text]
  • Patient's Knowledge and Use of Sublingual Glyceryl Trinitrate Therapy in Taiping Hospital, Malaysia
    World Academy of Science, Engineering and Technology International Journal of Pharmacological and Pharmaceutical Sciences Vol:8, No:10, 2014 Patient’s Knowledge and Use of Sublingual Glyceryl Trinitrate Therapy in Taiping Hospital, Malaysia Wan Azuati Wan Omar, Selva Rani John Jasudass, Siti Rohaiza Md Saad sensitive. They should therefore be stored in a tightly capped Abstract—Background: The objectives of this study were to original bottle (amber glass bottle) in a cool dry place [3]. assess patient’s knowledge of appropriate sublingual glyceryl Kimble &Kunik (2000) suggested that patient’s access to trinitrate (GTN) use as well as to investigate how patients commonly the medication& confidence in ability to use it, DO NOT store and carry their sublingual GTN tablets. Methodology: This was assure appropriate use [4]. The study found that 65% of the a cross-sectional survey, using a validated researcher-administered questionnaire. The study involved cardiac patients receiving subjects lacked knowledge on the proper use of SL GTN, plus sublingual GTN attending the outpatient and inpatient departments of a significant 32% used the drug for other symptoms. In Taiping Hospital, a non-academic public care hospital. The minimum another study done by Gallagher et al. (2010) involved a total calculated sample size was 92, but 100 patients were conveniently of 89 cardiac patients in Australia, only 43% claimed that they sampled. Respondents were interviewed on 3 areas, including have received related instruction before [5]. In the same study, demographic data, knowledge and use of sublingual GTN. Eight they found that although majority knew the importance of the items were used to calculate each subject’s knowledge score and six items were used to calculate use score.
    [Show full text]
  • AN ANALYSIS of ALI BABA BUJANG LAPOK and TIGA ABDUL Idea
    e-ISSN 2785-9444 VOL 1, NO 1 (JUNE) 2021: 39-48 Muslim Youth Movement of Malaysia (ABIM) Malaysian Journal of Islamic Movements and Muslim Societies مجلة ماليزية للحركات والمجتمعات اﻹسﻻمية Submission Date: 18/04/2021 Accepted Date: 3/05/2021 Publication Date: 30/06/2021 THE IDEAS OF COSMOPOLITAN ISLAM IN FILMS: AN ANALYSIS OF ALI BABA BUJANG LAPOK AND TIGA ABDUL Idea Kosmopolitan Islam di dalam Filem: Sebuah Analisis Terhadap Filem Ali Baba Bujang Lapok dan Tiga Abdul Mohammad Syazwannuddin Bin Shaharuddin1 International Institute of Islamic Thought and Civilization (ISTAC) [email protected] Abstract This paper aims to examine the notion of cosmopolitan Islam in the selected P. Ramlee films, Ali Baba Bujang Lapok (1960) and Tiga Abdul (1964). These films were chosen since it contained the theme of familial relationship and wealth by telling the story using the fantasy setting that had similarity to the city of Baghdad or Istanbul. By analyzing the main themes of each film, it had been found that his films contained ideas related to the changing family values in Malaya and Singapore, the effect of modernity and globalization to Malay language and the influences of Arab, Persian, and Turkish culture in the modern Malay society. As a man of his time, P. Ramlee’s film helps us to understand the aspirations and concerns of the Muslims at the onset of Malayan independence and Malaysia formations. Keywords: film, P. Ramlee, cosmopolitan, modernity, globalization Abstrak Artikel ini ditulis untuk mengkaji tanggapan mengenai Islam kosmpolitan di dalam filem-filem P. Ramlee yang terpilih iaitu Ali Baba Bujang Lapok (1960) dan Tiga Abdul (1964).
    [Show full text]